Change search criteria ↓

Search results

46 projects found matching your search criteria:

  1. 1. The role of epigenetic readers from BET family in the emergence and treatment of schizophrenia-like abnormalities in a n…

    Principal investigator: prof. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ4

  2. 2. The role of clozapine in moderating the biological effects of miR-181b-5p and miR-34a-5p in the context of schizophrenia…

    Principal investigator: Marek Mateusz Kotas

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 24, Panel: NZ5

  3. 3. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud…

    Principal investigator: dr Magdalena Białoń

    Instytut Farmakologii PAN

    Call: PRELUDIUM 21, Panel: NZ7

  4. 4. Evaluation of the brain microbiome and proteome as well as the role of fecal microbiota transplantation (FMT) in schizop…

    Principal investigator: dr Dominika Salamon

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ5

  5. 5. In search of the neuropsychophysiological underpinnings of impaired figurative language comprehension in schizophrenia: …

    Principal investigator: dr Przemysław Adamczyk

    Uniwersytet Jagielloński, Wydział Filozoficzny

    Call: OPUS 21, Panel: HS6

  6. 6. Role of perceptual priors, metacognitive beliefs and attention functioning in auditory hallucinations of schizophrenia p…

    Principal investigator: dr Joachim Bazyli Kowalski

    Instytut Psychologii PAN

    Call: SONATINA 4, Panel: HS6

  7. 7. The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni…

    Principal investigator: dr Paulina Agnieszka Cieślik

    Instytut Farmakologii PAN

    Call: PRELUDIUM 16, Panel: NZ7

  8. 8. Mechanisms of self-disturbances in a group of people suffering from schizophrenia and in a group at risk of developing p…

    Principal investigator: dr Renata Pionke-Ubych

    Instytut Psychologii PAN

    Call: PRELUDIUM 16, Panel: HS6

  9. 9. The role of gut microbiota and permeability in the pathophysiology of schizophrenia - in search of the mechanisms underl…

    Principal investigator: dr hab. Błażej Andrzej Misiak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

    Call: OPUS 16, Panel: NZ5

  10. 10. Behavioural and psychophysiological markers of response to social and non-social stressors in schizophrenia - a virtual …

    Principal investigator: Anna Maria Schudy

    Instytut Psychologii PAN

    Call: PRELUDIUM 15, Panel: HS6

  11. 11. Study of structural and functional neural correlates of the newly discovered implicit motor learning impairments in schi…

    Principal investigator: Adrian Andrzej Chrobak

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: PRELUDIUM 14, Panel: NZ4

  12. 12. Comparative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) and olanzapine on the cognitive dysfunction meas…

    Principal investigator: dr hab. Agnieszka Wąsik

    Instytut Farmakologii PAN

    Call: OPUS 13, Panel: NZ7

  13. 13. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra…

    Principal investigator: dr hab. Zofia Maria Rogóż

    Instytut Farmakologii PAN

    Call: OPUS 12, Panel: NZ7

  14. 14. The neural circuitry underlying the generation of high frequency oscillations (HFO) in olfactory brain regions in a rat …

    Principal investigator: dr hab. Mark Jeremy Hunt

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 12, Panel: NZ4

  15. 15. The role of brain networks in social information processing in schizophrenia - an investigation with multimodal brain im…

    Principal investigator: dr Łukasz Piotr Okruszek

    Instytut Psychologii PAN

    Call: SONATA 12, Panel: HS6

  16. 16. Characteristics of the neural correlates of diminished metaphor comprehension in schizophrenia

    Principal investigator: dr Przemysław Adamczyk

    Uniwersytet Jagielloński, Wydział Filozoficzny

    Call: OPUS 12, Panel: HS6

  17. 17. Synthesis and pharmacological characterization of structurally diverse chemical analogues of compound PO-10 as multiple …

    Principal investigator: dr hab. Agnieszka Zagórska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 11, Panel: NZ7

  18. 18. The role of the neuron-microglia CX3CL1-CX3CR1 and CD200-CD200R protein systems in molecular mechanisms of antipsychotic…

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 10, Panel: NZ7

  19. 19. Neurocognitive mechanisms and their associations with social functioning in schizophrenia patients.

    Principal investigator: Martyna Joanna Krężołek

    Warszawski Uniwersytet Medyczny, II Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim oraz Oddziałem Fizjoterapii

    Call: PRELUDIUM 10, Panel: HS6

  20. 20. Genetic background of schizophrenia and somatic mutations in brain tissue

    Principal investigator: Krystyna Barbara Wasilewska

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 10, Panel: NZ5

  21. 21. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas…

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  22. 22. The effects of ligands of the alpha7 nicotinic acetylcholine receptors on complex cognitive processes and social behavio…

    Principal investigator: Agnieszka Teresa Potasiewicz

    Instytut Farmakologii PAN

    Call: PRELUDIUM 8, Panel: NZ7

  23. 23. The effect of social stress during adolescence on the psychotic symptoms development and epigenetic mechanisms in the ne…

    Principal investigator: dr hab. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ4

  24. 24. Sense of humor in schizophrenia - characteristics of the neuronal basis of processes related to humor comprehension defi…

    Principal investigator: dr Przemysław Adamczyk

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 7, Panel: HS6

  25. 25. Instructional control of reinforcement learning in schizophrenia: investigation using genetic, behavioral and neurocompu…

    Principal investigator: dr hab. Dorota Frydecka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski Kształcenia Podyplomowego

    Call: SONATA 6, Panel: HS6

  26. 26. Neurophysiological and neuropsychological correlates of emotion - cognition interaction in schizophrenia.

    Principal investigator: Łukasz Piotr Okruszek

    Uniwersytet Warszawski, Wydział Psychologii

    Call: PRELUDIUM 5, Panel: HS6

  27. 27. The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

    Principal investigator: dr Ewelina Bator

    Instytut Farmakologii PAN

    Call: PRELUDIUM 4, Panel: NZ4

  28. 28. Identification of mechanisms responsible for calcium homeostasis deregulation and concomitant disturbances in GABA metab…

    Principal investigator: dr Tomasz Boczek

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: SONATA 3, Panel: NZ4

  29. 29. The role of genetic variation in one-carbon metabolism cycle in the etiology of the metabolic syndrome in patients with …

    Principal investigator: Błażej Andrzej Misiak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski Kształcenia Podyplomowego

    Call: PRELUDIUM 2, Panel: NZ5

  30. 30. Metabolic and behavioral characterization of mice with conditional knockout of Tcf7l2, a risk gene for diabetes and schi…

    Principal investigator: dr Andrzej Paweł Nagalski

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 10, Panel: NZ4

  31. 31. 5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param…

    Principal investigator: prof. Anna Małgorzata Wesołowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 10, Panel: NZ7

  32. 32. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  33. 33. Semantic associations during creative thinking in the healthy and the distorted mind

    Principal investigator: dr Hanna Wiktoria Kucwaj

    Uniwersytet Jagielloński, Wydział Filozoficzny

    Call: PRELUDIUM 20, Panel: HS6

  34. 34. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  35. 35. Relevance of epigenetic regulation of the FKBP5 gene in moderating the association between psychosocial stress and psych…

    Principal investigator: dr hab. Błażej Andrzej Misiak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: OPUS 21, Panel: HS6

  36. 36. Molecular profiling of novel antipsychotic drug candidates

    Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

    Call: OPUS 20, Panel: NZ7

  37. 37. Amotl1 mutant mice as a novel model of human psychiatric disorders associated with social dysfunctions

    Principal investigator: dr hab. Tomasz Jacek Prószyński

    Wrocławskie Centrum Badań EIT+ Sp. z o.o.

    Call: OPUS 17, Panel: NZ3

  38. 38. The role of nitric oxide-dependent pathways in the procognitive effects of muscarinic and metabotropic glutamate recepto…

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 17, Panel: NZ7

  39. 39. Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  40. 40. Prader-Willi Syndrome as a neurodevelopmental model of the immuno-inflammatory concept of psychotic disorders.

    Principal investigator: Maja Maria Krefft

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

    Call: PRELUDIUM 9, Panel: NZ5

  41. 41. Molecular mechanism of unique action of clozapine in the context of GPCR.

    Principal investigator: dr Agata Faron-Górecka

    Instytut Farmakologii PAN

    Call: OPUS 8, Panel: NZ7

  42. 42. Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

    Principal investigator: Katarzyna Karolina Kamińska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 5, Panel: NZ7

  43. 43. Description of the molecular impact of clozapine on PC12 cells - proteomic study

    Principal investigator: Urszula Jankowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 5, Panel: NZ3

  44. 44. The effects of positive allosteric modulators of alpha7 nicotinic acetylcholine receptors on complex cognitive processes…

    Principal investigator: dr hab. Agnieszka Anna Nikiforuk

    Instytut Farmakologii PAN

    Call: OPUS 4, Panel: NZ7

  45. 45. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

    Call: MAESTRO 3, Panel: NZ7

  46. 46. Brain regions that mediate antipsychotic-induced changes in oscillatory activity recorded in the nucleus accumbens

    Principal investigator: dr Mark Jeremy Hunt

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 2, Panel: NZ4

Graphic design and implementation: Jakub Piotrowski